Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Tomáš Fait"'
Publikováno v:
BMC Pregnancy and Childbirth, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Although the percentage of cesarean sections (CS) in Czechia is below the average of that of other developed countries (23.6%), it still exceeds WHO recommendations (15%). The first aim of the study is to examine the association b
Externí odkaz:
https://doaj.org/article/e99df6f9f9ee475c8acdb93e2b343dfc
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0284159 (2023)
BackgroundFertility postponement, which has comprised the most significant reproductive trend in developed countries over the last few decades, involves a number of social, personal and health consequences. The length of stay (LOS) in hospital follow
Externí odkaz:
https://doaj.org/article/44d785e8cfe94d5882a792bc6ddccf81
Autor:
Tomáš Fait
Publikováno v:
Dermatologie pro praxi. 16:145-149
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf4d87e93b9efa9e2645c82992b760af
https://doi.org/10.36290/der.2022.028
https://doi.org/10.36290/der.2022.028
Autor:
Tomáš, Fait, Jan, Janota
Publikováno v:
Ceska gynekologie. 87(6)
Delayed umbilical cord clamping is a standard procedure for active management of the 3rd stage of labour. There are benefits associated with more than a 30 second delay, but 1 minute is usually recommended. For newborns, increased iron reserves are i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9523a10cecd4858213206cd7502661
https://pubmed.ncbi.nlm.nih.gov/36543591
https://pubmed.ncbi.nlm.nih.gov/36543591
Autor:
Tomáš Fait
Publikováno v:
Medicína pro praxi. 17:253-257
Lidske papilomaviry (HPV) jsou nejvýznamnějsim přicinným faktorem vzniku karcinomu hrdla děložniho, ale i dalsich malignich i benignich lezi ženskeho i mužskeho genitalu a castecně i dalsich oblasti přechodu dlaždicoveho a cylindrickeho ep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ae7d19c2e0a589dac0f7108273ecb14
https://doi.org/10.36290/med.2020.048
https://doi.org/10.36290/med.2020.048
Autor:
Tomáš Fait
Publikováno v:
Medicína pro praxi. 16:254-256
Vulvovaginalni dyskomfort je castým problemem gynekologických pacientek. Castěji než infekce je přicinou dysmikrobie. Masklon k recidivam. V lecbě i prevenci se vedle antiinfekcni terapie doporucuje obnoveni posevniho prostředi probiotiky.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db082024481be3300e08c06bbe5e0dcd
https://doi.org/10.36290/med.2019.039
https://doi.org/10.36290/med.2019.039
Autor:
Tomáš Fait
Publikováno v:
Journal of Advances in Medicine and Medical Research. 22:1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c51fc37d98c14c14a6c729a06d9fcd43
https://doi.org/10.9734/jammr/2017/34500
https://doi.org/10.9734/jammr/2017/34500
Publikováno v:
Casopis lekaru ceskych. 158(3-4)
The various health risks associated with the increasing age of mothers at childbirth include the low birth weight of new-born children. The aim of the article is to verify the relationship between the birth weight of new-born children and the age of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d3a7910a33130476e82f1b9cd9466b66
https://pubmed.ncbi.nlm.nih.gov/31416318
https://pubmed.ncbi.nlm.nih.gov/31416318
Autor:
Tomáš, Fait
Publikováno v:
Casopis lekaru ceskych. 158(3-4)
About 40 % of woman suffer from vulvovaginal atrophy after menopausal transition. It is very important to put question on this problem, because about 70 % of them are not able to start discussion on it. Regarding treatment, vaginal low doses estriol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14e163b1765cdb4c72776e3d9d8a361f
https://pubmed.ncbi.nlm.nih.gov/31416315
https://pubmed.ncbi.nlm.nih.gov/31416315
Autor:
Tomáš, Fait
Publikováno v:
Casopis lekaru ceskych. 158(3-4)
Tibolon is the only therapeutic approach to climacteric symptoms, prevention of osteoporosis and urogenital atrophy with the same efficacy as hormone replacement therapy. Tibolon has more positive effects on sexuality and mood changes in menopausal w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::18893ee233d56d1a042cba34ea10aa3c
https://pubmed.ncbi.nlm.nih.gov/31416316
https://pubmed.ncbi.nlm.nih.gov/31416316